The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...

Kyverna Therapeutics announced positive topline data from a phase II trial of mivocabtagene autoleucel, a chimeric antigen ...

Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...

One of the most common causes of epilepsy is a structural brain abnormality. “Epilepsy can result from structural issues in ...

Autoimmune epilepsy is a newly defined group of conditions characterized by recurrent seizures associated with autoimmunity. Cancer and infections are two potential triggers. Epilepsy is a seizure ...

Observational data point to a relationship between the vascular system and epilepsy beyond the brain. Among people ages 40 and older, heart attack survivors had a disproportionately greater risk of ...

Researchers aimed to identify the characteristics, treatment pathways, and outcomes associated with epilepsy with eyelid myoclonia (EEM). Epilepsy with eyelid myoclonia (EEM) is a rare and ...

A recent study points to a potential link between GLP-1 drugs and its ability to reduce risk of epilepsy in people with type 2 diabetes. GLP-1 drugs (semaglutide) are those which mimic the function of ...

People with a genetic predisposition for Alzheimer's disease may have an increased risk of epilepsy and people with a certain type of epilepsy may have an increased risk of developing Alzheimer's ...

Slowly and inexorably, Alzheimer’s disease steals a person away. Taking memory and cognitive abilities. Pilfering personality and social skills. Robbing a person of the ability to care for herself.